Based on our previous study on minor entity-overlapping therapeutic potential between GIT and lymphomas [3], we here focused on cellular lysates made of two different GIT cell lines, namely MLH1−/− A7450 and 328. This evidence concerns the gene MLH1 and lymphoma.